PRICE T ROWE ASSOCIATES INC /MD/ - UNIQURE NV ownership

UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 1 filers reported holding UNIQURE NV in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of UNIQURE NV
ValueSharesWeighting
Q3 2023$109
-95.4%
16,100
-92.2%
0.00%
Q2 2023$2,370
-98.9%
206,715
+1697.5%
0.00%
Q3 2022$216,000
-97.6%
11,500
-97.6%
0.00%
-100.0%
Q2 2022$8,871,000
+48.6%
475,917
+44.1%
0.00%0.0%
Q1 2022$5,969,000
-78.8%
330,317
-75.7%
0.00%
-66.7%
Q4 2021$28,180,000
-45.1%
1,358,709
-15.2%
0.00%
-40.0%
Q3 2021$51,285,000
-8.0%
1,602,166
-11.4%
0.01%0.0%
Q2 2021$55,722,000
-16.9%
1,809,161
-9.1%
0.01%
-28.6%
Q1 2021$67,022,000
-7.5%
1,989,369
-0.8%
0.01%0.0%
Q4 2020$72,429,000
+50.9%
2,004,682
+53.8%
0.01%
+16.7%
Q3 2020$47,993,000
+3.7%
1,303,083
+26.9%
0.01%0.0%
Q2 2020$46,259,000
+59.0%
1,026,606
+67.5%
0.01%
+20.0%
Q1 2020$29,086,000
-17.7%
612,987
+24.4%
0.01%0.0%
Q4 2019$35,323,000
+158.5%
492,926
+42.0%
0.01%
+150.0%
Q3 2019$13,662,000
-49.5%
347,096
+0.3%
0.00%
-50.0%
Q2 2019$27,055,000
+51.5%
346,188
+15.7%
0.00%
+33.3%
Q1 2019$17,854,000
+152.4%
299,308
+21.9%
0.00%
+200.0%
Q4 2018$7,074,000
-15.0%
245,466
+7.3%
0.00%0.0%
Q3 2018$8,324,000228,7460.00%
Other shareholders
UNIQURE NV shareholders Q4 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 955,424$32,188,0005.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 282,034$9,490,0002.51%
Nantahala Capital Management 1,672,891$56,360,0001.65%
Henry James International Management Inc. 149,053$5,022,0001.51%
Nantahala Capital Management 1,500,000$50,535,0001.48%
Voss Capital, LLC 90,000$3,032,0001.26%
P.A.W. CAPITAL CORP 30,000$1,011,0000.89%
Sofinnova Investments, Inc. 427,122$14,390,0000.86%
Caption Management, LLC 1,078,800$36,343,0000.78%
Sivik Global Healthcare LLC 61,768$2,081,0000.76%
View complete list of UNIQURE NV shareholders